Literature DB >> 14871285

Successful oesophageal pH monitoring with a catheter-free system.

E M Ward1, K R Devault, E P Bouras, M E Stark, H C Wolfsen, D M Davis, S I Nedrow, S R Achem.   

Abstract

BACKGROUND: Traditional catheter-based oesophageal pH testing is limited by patient discomfort and the tendency for patients to alter their diet and activities during the study. A catheter-free pH monitoring system (Bravo) designed to avoid these problems has recently become available, but the advantages and limitations of this device have not been fully explored. AIM: To report our initial experience with this new technology.
METHODS: The records of consecutive patients undergoing Bravo pH monitoring were reviewed. The squamo-columnar junction was localized endoscopically and the pH capsule was placed 6 cm above this junction. All patients were re-endoscoped immediately following placement to document mucosal attachment. Patients were monitored for 24-48 h and then returned the radiotelemetry recording device. Data were subsequently downloaded to a personal computer.
RESULTS: Sixty studies were performed over an 11-month period. In seven of the 60 (12%), the probe did not attach properly, but in six of these a replacement probe was prepared and deployed without difficulty. In one case, the probe could not be attached after two attempts and the procedure was abandoned. During one procedure, the probe was attached to the mucosa at a point 9 cm from the squamo-columnar junction, but a positive test result was obtained. In two cases, the data were not initially retrievable from the recorder, but in one case the manufacturer was able to retrieve the data overnight. Finally, two patients were away from the data recorder for extended periods, resulting in a loss of data, in two cases, but there was sufficient information for interpretation in both studies. Therefore, adequate diagnostic data were obtained in 58 of the 60 (97%) studies.
CONCLUSIONS: Catheter-free pH testing is a major advance in patient convenience and comfort. The technical difficulties associated with this new technology are minimal and appear to be no more frequent than those seen with catheter-based systems.

Entities:  

Mesh:

Year:  2004        PMID: 14871285     DOI: 10.1111/j.1365-2036.2004.01868.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

1.  New method for long-term monitoring of intragastric pH.

Authors:  Shouko Ono; Mototsugu Kato; Yuji Ono; Masahiro Asaka
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

2.  A novel placement method of the Bravo wireless pH monitoring capsule for measuring intragastric pH.

Authors:  Jae Hyuck Chang; Myung Gyu Choi; Dong-Seok Yim; Yu Kyung Cho; Jae Myung Park; In Seok Lee; Sang Woo Kim; In Sik Chung
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

Review 3.  New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance.

Authors:  Jason A Wilson; Marcelo F Vela
Journal:  Curr Gastroenterol Rep       Date:  2008-06

4.  Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.

Authors:  Valentine C Ibekwe; Hala M Fadda; Emma L McConnell; Mandeep K Khela; David F Evans; Abdul W Basit
Journal:  Pharm Res       Date:  2008-05-09       Impact factor: 4.200

Review 5.  The role of oesophageal physiological testing in the assessment of noncardiac chest pain.

Authors:  Henriette Heinrich; Rami Sweis
Journal:  Ther Adv Chronic Dis       Date:  2018-09-11       Impact factor: 5.091

6.  Technical problems produced by the Bravo pH test in nonerosive reflux disease patients.

Authors:  Andrés de Hoyos; Edgar Alain Esparza
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

7.  Endoscopic pH monitoring for patients with suspected or refractory gastroesophageal reflux disease.

Authors:  B G Turner; J R Saltzman; L Hua; R Maurer; Natan Feldman; D L Carr-Locke; R Burakoff; J J Liu
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

8.  48-Hour pH monitoring increases the risk of false positive studies when the capsule is prematurely passed.

Authors:  Atif Iqbal; Yong Kwon Lee; Michelle Vitamvas; Dmitry Oleynikov
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.452

9.  Esophagogastroduodenoscopy with conscious sedation does not interfere with catheter-based 24-h pH monitoring.

Authors:  Yung-Kuan Tsou; Jau-Min Lien; Chin-Kuo Chen; Cheng-Hui Lin; Hsing-Yu Chen; Mu-Shien Lee
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

10.  Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system.

Authors:  Emile P Chen; Kelly M Mahar Doan; Samm Portelli; Robert Coatney; Vernal Vaden; Wei Shi
Journal:  Pharm Res       Date:  2007-07-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.